EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2023 -0.0008
March 31, 2023 -0.0132
December 31, 2022 0.0198
September 30, 2022 0.0018
June 30, 2022 -0.0425
March 31, 2022 -0.0196
December 31, 2021 -0.0395
September 30, 2021 -0.4185
June 30, 2021 0.4462
March 31, 2021 -3.642
December 31, 2020 -2.652
September 30, 2020 -0.0188
June 30, 2020 -17.62
March 31, 2020 -26.73
December 31, 2019 -129.42
September 30, 2019 3947.06
June 30, 2019 -314.44
March 31, 2019 -29.25
December 31, 2018 1404.00
September 30, 2018 -8271.56
June 30, 2018 -97.88
March 31, 2018 -1230.19
December 31, 2017 -28199.81
September 30, 2017 -54208.13
June 30, 2017 -29046.94
Date Value
March 31, 2017 -84231.56
December 31, 2016 -54562.50
September 30, 2016 -49494.38
June 30, 2016 -16875.00
March 31, 2016 -16875.00
December 31, 2015 -45950.62
September 30, 2015 -67500.00
June 30, 2015 -84375.00
March 31, 2015 -101250.0
December 31, 2014 -84375.00
September 30, 2014 -84375.00
June 30, 2014 -101250.0
March 31, 2014 -118125.0
December 31, 2013 -118125.0
September 30, 2013 -67500.00
June 30, 2013 -67500.00
March 31, 2013 -101250.0
December 31, 2012 -100321.9
September 30, 2012 -135000.0
June 30, 2012 -67500.00
March 31, 2012 -236250.0
December 31, 2011 -151875.0
September 30, 2011 -135000.0
June 30, 2011 -135000.0
March 31, 2011 -33750.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Savara, Inc. -0.1587
Vericel Corp. 0.0422
Biogen, Inc. 0.6557